Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 257 followers
Latest posts
Last updated about 8 hours ago
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation...
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 47, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation: 02/06/1998, Revision: 63, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation...
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 23, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation...
Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 2, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date...
Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Date of authorisation: 15/05/2009, Revision: 35, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Date of...
Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 5, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation...
Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 9, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Litak, cladribine, Date of authorisation: 14/04/2004, Revision: 8, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Litak, cladribine, Date of authorisation...
Human medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation: 17/09/2007, Revision: 28, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Yondelis, trabectedin, Date of authorisation...
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation...